You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

limited disease small-cell lung cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status
  • Advanced Cancer
  • Birmingham, Alabama
  • +42 more
Jan 28, 2020

Post Operative Pain Trial in Seattle (Dose of 0.5% Ropivacaine)

Recruiting
  • Post Operative Pain
  • Dose of 0.5% Ropivacaine
  • Seattle, Washington
    Virginia Mason Medical Center
May 11, 2023

Asthma in Children Trial in Montpellier (Airway Oscillation System)

Not yet recruiting
  • Asthma in Children
  • Airway Oscillation System
  • Montpellier, France
    CHU de Montpellier
Feb 15, 2023

Melanoma (Skin), Melanoma, Stage II Trial in Manchester (Nivolumab 10 MG/ML)

Recruiting
  • Melanoma (Skin)
  • Melanoma, Stage II
  • Nivolumab 10 MG/ML
  • Manchester, Greater Manchester, United Kingdom
    The Christie NHS Foundation Trust
Nov 11, 2021

Pediatric Hydroxyurea Phase III Clinical Trial Follow-up

Completed
Has Results
  • Sickle Cell Anemia
  • Birmingham, Alabama
  • +13 more
Aug 10, 2020

Driven by Disease Biology et/or Immunoactivity (PROMETEO)

Recruiting
  • Oligometastatic Prostate Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Sep 25, 2023

    COPD Acute Exacerbation Trial in France (ECCO2R)

    Not yet recruiting
    • COPD Acute Exacerbation
    • ECCO2R
    • Angers, France
    • +19 more
    Sep 15, 2022

    Endoscopic Sinus Surgery, Fentanyl Trial in Assiut (Saline 0.9%, Levobupivacaine Hydrochloride, Fentanyl)

    Recruiting
    • Endoscopic Sinus Surgery
    • Fentanyl
    • Saline 0.9%
    • +3 more
    • Assiut, Egypt
      Assiut governorate
    Dec 3, 2021

    Acute and Long-term Cardiovascular Toxicity After Modern

    Recruiting
    • Breast Neoplasms
    • Cardiovascular Diseases
      • Trondheim, Norway
      • +1 more
      Dec 5, 2022

      Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

      Recruiting
      • Esophagus Cancer
      • Xiamen, Fujian, China
        ShanghaiZhongshan
      Apr 8, 2023

      Pulmonary Nodule, Ablation Trial (Hydromorphone Hydrochloride, Morphine HCl)

      Not yet recruiting
      • Pulmonary Nodule
      • Ablation
      • Hydromorphone Hydrochloride
      • Morphine hydrochloride
      • (no location specified)
      Apr 28, 2023

      Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

      Not yet recruiting
      • Endometrial Carcinoma
      • Tumor Molecular Features Screening Model
      • open surgery
      • laparoscopic surgery
      • (no location specified)
      Jun 7, 2023

      Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)

      Recruiting
      • Congenital Hyperinsulinism
      • Insulinoma
      • Fluorodopa F 18
      • Fort Worth, Texas
        Cook Children's Medical Center
      Dec 8, 2022

      Carcinoma, Non-Small Cell Lung Trial (sequential DEB-BACE and Arotinib and Tirelizumab, DEB-BACE alone)

      Not yet recruiting
      • Carcinoma, Non-Small Cell Lung
      • sequential DEB-BACE and Arotinib and Tirelizumab
      • DEB-BACE alone
      • (no location specified)
      May 14, 2022

      Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +3 more
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      May 17, 2023

      Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell

      Recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • CT041 autologous CAR T-cell injection
      • Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）
      • Hefei, Anhui, China
      • +9 more
      Feb 13, 2022

      Solid Tumors, KRAS Mutation Trial in Worldwide (BI 1823911, BI 1701963, Midazolam)

      Recruiting
      • Solid Tumors, KRAS Mutation
      • BI 1823911
      • +2 more
      • New York, New York
      • +8 more
      Aug 10, 2022

      Breast Cancer Metastatic, Breast Cancer Female, Breast Cancer Recurrent Trial in Hanoi, Ho Chi Minh City (Faceptor, Herceptin,

      Completed
      • Breast Cancer Metastatic
      • +2 more
      • Hanoi, Vietnam
      • +1 more
      Mar 19, 2022

      Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

      Active, not recruiting
      • Autologous Hematopoietic Stem Cell Transplant Recipient
      • +4 more
      • Duarte, California
        City of Hope
      Mar 17, 2022

      Prostate Cancer, Radiotherapy Side Effect Trial in Graz (Hypofractionated radiotherapy)

      Terminated
      • Prostate Cancer
      • Radiotherapy Side Effect
      • Hypofractionated radiotherapy
      • Graz, Austria
        Medical University of Graz
      Sep 29, 2022

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

      Recruiting
      • Acute Myeloid Leukemia
      • +6 more
      • Biospecimen Collection
      • +2 more
      • Orange, California
      • +9 more
      Jan 27, 2023

      Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

      Recruiting
      • Neoplasms
      • +12 more
      • Nanjing, Jiangsu, China
        Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
      Oct 28, 2023

      Development ofTherapeutic Education Program for Metastatic

      Recruiting
      • Prostate Cancer
      • Focus group creation
      • Workshop
      • Nîmes, France
        CHU de Nimes
      Sep 20, 2022

      Cervical Cancer Trial in Suzhou (Chemoradiotherapy + Adjuvant chemo and Zimberelimab, Chemoradiotherapy (small pelvic) +

      Recruiting
      • Cervical Cancer
      • Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
      • Chemoradiotherapy (small pelvic) + Zimberelimab
      • Suzhou, Jiangsu, China
        The Affiliated Suzhou Hospital of Nanjing Medical University
      May 14, 2023

      Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)

      Active, not recruiting
      Has Results
      • Brain and Central Nervous System Tumors
      • filgrastim
      • +5 more
      • Durham, North Carolina
      • +8 more
      Dec 17, 2021